Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Pfizer Inc.    PFE   US7170811035

PFIZER INC. (PFE)

393
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on PFIZER INC.
11:57a Government warns off BP suitors now Shell unavailable as 'white knight'
10:18a PFIZER : Kano Trovan Victims Want Buhari to Review Case
09:01a PFIZER : China Jo-Jo Drugstore Signed a New Sales Incentive Agreement with Wyeth..
02:49a PFIZER : Secures U.S. FDA Breakthrough Therapy Designation for XALKORI (crizotin..
02:48a PFIZER : Achieves U.S. FDA Breakthrough Therapy Designation for XALKORI (crizoti..
02:46a PFIZER : Updates on Phase 3 Study of Inotuzumab Ozogamicin
04/26 PFIZER : Green chemistry pharmaceuticals launched in Pfizer's Groton labs going ..
04/26 Government would oppose any takeover of BP -FT
04/26DJMARKET SNAPSHOT : Apple, Energy, Health Care Earnings To Dominate Week
04/25 ASTRAZENECA : sees sales hit by copycats
04/24 PFIZER : Federal Lipitor Lawsuits Progress, as New Status Report Details Prepara..
04/24DJBiogen First-Quarter Profit, Revenue Miss Expectations -- Update
04/24DJAstraZeneca Reports Fall in First-Quarter Profit -- 2nd Update
04/24DJBiogen Profit, Revenue Miss Expectations
04/24 AstraZeneca looks beyond Nexium hit with new cancer deals
04/24 ASTRAZENECA : Facing Modest Shareholder Revolt On Pay - Sky News (PRESS)
04/24DJAstraZeneca Reports Fall in First-Quarter Profit
04/24 PFIZER : Gets U.S. FDA Breakthrough Therapy Designation for XALKORI (crizotinib)
04/23 ASTRAZENECA : Braced For Investor Pay Protest
04/23 PFIZER : Hosts Annual Meeting Of Shareholders
04/23 PFIZER : Lilly Reports First-Quarter 2015 Results
04/22DJMeet Pharma's Newest Movers and Shakers, Driving M&A
04/22 PFIZER : Vendor showcase gears up for CURE Commons
04/22DJMeet Pharma's Newest Movers and Shakers, Driving M&A
04/22 PFIZER : Invites Public to Listen to Webcast of April 23 Annual Meeting of Share..
04/22 PFIZER : Launches 2014 Integrated Annual Review
04/22 PFIZER : Announces PALOMA-3 Trial For IBRANCE® Palbociclib Stopped Early Due To ..
04/22 PAIN THERAPEUTICS : Resumes Responsibility for REMOXY
04/22 Excitement over new immunotherapy drugs
04/22 PFIZER : Receives U.S. FDA Breakthrough Therapy Designation For XALKORI (crizoti..
04/21 PFIZER : Xalkori wins breakthrough status
04/21 PFIZER : says leukemia drug met 1 goal in study
04/21 PFIZER : Receives U.S. FDA Breakthrough Therapy Designation For XALKORI® (crizot..
04/21 PFIZER : Phase 3 Study Of Inotuzumab Ozogamicin Meets Primary Endpoint In Adult ..
04/20 PFIZER : Axium Healthcare Pharmacy Dispensing New Breakthrough Breast Cancer Dru..
04/20 DOW MOVERS : Ge, ibm
04/20 PFIZER : New decision curbs drug price gouging
04/20 PFIZER : Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer In..
04/20 MERCK KGAA : Global Strategic Partners Merck and Pfizer Initiate Phase III Study..
04/20 PFIZER : Reports PALOMA-3 Trial For IBRANCE (Palbociclib) Stopped Early Due To E..
04/20 MACROGENICS : Presents Pre-Clinical Data on its Multivalent DR5 DART at the AACR..
04/19 PFIZER : New decision curbs drug price gouging
04/18 PFIZER : GlycoMimetics Updates on Pfizer's Plans to Initiate Phase 3 Trial with ..
04/18 PFIZER : Rolls Out PCSK9 Competitive Grants Program
04/18 HOSPIRA : Sets Date for 1st-Quarter 2015 Results Release
04/16 PFIZER : Invites Public to Listen to Webcast of April 23 Annual Meeting of Share..
04/16 MERCK KGAA : Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfize..
04/16 PFIZER : Launches 2014 Integrated Annual Review
04/16 Rothschild's Wright to take top UK Takeover panel role
04/16 PFIZER : Kathrin U. Jansen, Ph.D., to Lead Pfizer's Vaccine Research and Develop..
04/16 PFIZER : Launches First Annual PCSK9 Competitive Grants Program to Advance Cardi..
04/16 PFIZER : Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman
04/16 MACROGENICS : Announces Presentations at AACR Annual Meeting 2015
04/16 PFIZER : Approved Pfizer breast cancer drug impresses in latest study
04/15 PFIZER : Ibrance wins another round in cancer fight
04/15DJPfizer Breast-Cancer Drug Study Meets Primary Endpoint -- Update
04/15DJPfizer Breast-Cancer Drug Study Meets Primary Endpoint
04/15DJPFIZER : Breast-Cancer Drug Study Meets Primary Endpoint
04/15 PFIZER : Announces PALOMA-3 Trial For IBRANCE® (Palbociclib) Stopped Early Due T..
04/15 PFIZER : House House Foreign Affairs Subcommittee on Africa, Global Health, Glob..
04/14DJEuropean M&A Deal Volume Rises, but Still Trails U.S.
04/14 Banks see talent flee amid healthcare M&A boom
04/14 HOSPIRA : Schedules 1st-Quarter 2015 Results Release
04/14 PFIZER : Kicks Off PCSK9 Competitive Grants Program
04/14 Insight - Banks see talent flee amid healthcare M&A boom
04/14 PharmaCyte Biotech Appoints Former Pfizer and Alchemia Executive to Board of ..
04/14 PharmaCyte Biotech Appoints Former Pfizer and Alchemia Executive to Board of ..
04/13 PFIZER : Impact Of International Cartels On Economy Of Developing Countries &nda..
04/12DJHow the Hottest Biotech Sprouted in Iowa
04/12DJFive Filipino Tech Startups to Watch
04/12 PFIZER : Names Kathrin Jansen to Lead Vaccine Research and Development Unit
04/12 PFIZER : BIND Therapeutics Secures Extension of Global Collaboration with Pfizer
04/12 PFIZER : Names Kathrin Jansen, Ph.D., as Its SVP of Vaccine Research and Develop..
04/10 PFIZER : GlycoMimetics Reports on Pfizer's Plans to Initiate Phase 3 Trial with ..
04/10 HOSPIRA : Schedules Date to Report First-Quarter 2015 Results
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Pfizer Inc. Technical Analysis Chart | PFE | US7170811035 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF